The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach
- PMID: 23320183
- PMCID: PMC3540741
- DOI: 10.1155/2012/725735
The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach
Abstract
Because of the risk of hormone-induced growth and spontaneous rupture of hepatocellular adenoma (HCA) during pregnancy, special considerations are required. Due to the scarcity of cases, there is no evidence-based algorithm for the evaluation and management of HCA during pregnancy. We think it should be questioned if it is justified to discourage pregnancy in all women with HCA. The biological behavior of this benign lesion might be less threatening than presumed and a negative advice concerning pregnancy has great impact on the lives of these young female patients. The balance between the pros and cons of hepatic adenomas and pregnancy should be reconsidered. In our center, pregnancy in women with an HCA up to 5 cm is no longer discouraged in close consultation with the patient, her partner, and members of the liver expert team.
Figures
References
-
- Baum JK, Holtz F, Bookstein JJ, Klein EW. Possible association between benign hepatomas and oral contraceptives. The Lancet. 1973;2(7835):926–929. - PubMed
-
- Lingeman CH. Liver cell neoplasms and oral contraceptives. The Lancet. 1974;1(7846, article 64) - PubMed
-
- Nissen ED, Kent DR, Nissen SE. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives. American Journal of Obstetrics and Gynecology. 1977;127(1):61–66. - PubMed
-
- Parangi S, Levine D, Henry A, Isakovich N, Pories S. Surgical gastrointestinal disorders during pregnancy. American Journal of Surgery. 2007;193(2):223–232. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
